BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7817382)

  • 21. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings.
    Johnsen HE; Mickelson E; Beatty PG; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):91-6. PubMed ID: 1533334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
    Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
    Blood; 1993 Apr; 81(7):1923-32. PubMed ID: 8461476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unrelated donor marrow transplantation in children.
    Balduzzi A; Gooley T; Anasetti C; Sanders JE; Martin PJ; Petersdorf EW; Appelbaum FR; Buckner CD; Matthews D; Storb R; Sullivan KM; Hansen JA
    Blood; 1995 Oct; 86(8):3247-56. PubMed ID: 7579422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture.
    Termijtelen A; Erlich HA; Braun LA; Verduyn W; Drabbels JJ; Schroeijers WE; van Rood JJ; de Koster HS; Giphart MJ
    Hum Immunol; 1991 Aug; 31(4):241-5. PubMed ID: 1680836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.
    Leung WH; Turner V; Richardson SL; Benaim E; Hale G; Horwitz EM; Woodard P; Bowman LC
    Hum Immunol; 2001 Apr; 62(4):399-407. PubMed ID: 11295473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
    van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
    Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Weston LE; Geczy AF; Farrell C
    Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
    Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
    Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
    Nademanee A; Schmidt GM; Parker P; Dagis AC; Stein A; Snyder DS; O'Donnell M; Smith EP; Stepan DE; Molina A
    Blood; 1995 Aug; 86(3):1228-34. PubMed ID: 7620176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
    Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
    Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
    Varney MD; Lester S; McCluskey J; Gao X; Tait BD
    Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unrelated donor matching for bone marrow transplantation.
    Chopek M; Alosco S; Salazar M; Yunis EJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1255-8. PubMed ID: 8442106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome.
    Bishara A; Brautbar C; Cohen I; Nagler A
    Hum Immunol; 1999 Sep; 60(9):833-9. PubMed ID: 10527390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank].
    Matsumoto K; Horibe K; Akatsuka Y; Minami S; Matsuyama T; Hirabayashi N; Tanimoto M; Yamada H; Sobue R; Morishima Y
    Rinsho Ketsueki; 1994 Aug; 35(8):729-37. PubMed ID: 7933558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
    Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definition of HLA-DQ as a transplantation antigen.
    Petersdorf EW; Longton GM; Anasetti C; Mickelson EM; Smith AG; Martin PJ; Hansen JA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15358-63. PubMed ID: 8986816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histocompatibility and bone marrow transplantation (BMT).
    Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.